dc.contributor.author | Tunçay, Eylem | |
dc.contributor.author | Güngör, Gökay | |
dc.contributor.author | Güngör, Sinem | |
dc.contributor.author | Saltürk, Cüneyt | |
dc.contributor.author | Aksoy, Emine | |
dc.contributor.author | Çiftaslan Gökşenoğlu, Nezihe | |
dc.contributor.author | Irmak, İlim | |
dc.contributor.author | Adıgüzel, Nalan | |
dc.date.accessioned | 2021-12-21T08:31:42Z | |
dc.date.available | 2021-12-21T08:31:42Z | |
dc.date.issued | 2019 | |
dc.identifier.issn | 2587-0998 | |
dc.identifier.issn | 2587-1404 | |
dc.identifier.uri | https://app.trdizin.gov.tr/makale/TXpRMU56VXpNdz09/antibiotherapy-and-mortality-rate-in-ventilator-associated-pneumonia-and-tracheobronchitis-due-to-acinetobacter-baumannii | |
dc.identifier.uri | https://doi.org/10.14744/scie.2019.58966 | |
dc.identifier.uri | http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/833 | |
dc.description.abstract | Objective: Ventilator-associated pneumonia (VAP) due to Acinetobacter baumannii (A. baumannii) has a high mortality rate in the intensive care unit (ICU). The guidelines recommendempirical antimicrobial therapy in cases of VAP; however, similar treatment | |
dc.description.abstract | Amaç: Yoğun bakım ünitesinde (YBÜ) Acinetobacter baumanii’ye (A. baumanii) bağlı gelişen ventilatör ilişkili pnömonide (VİP) mortalite
yüksektir. VİP’te ampirik antimikrobiyal tedavinin önemi rehberler tarafından vurgulanırken ventilatör ilişkili trakeob | |
dc.language.iso | English | |
dc.title | Antibiotherapy and Mortality Rate in
Ventilator-Associated Pneumonia
and Tracheobronchitis due to
Acinetobacter Baumannii | |
dc.title.alternative | Acinetobacter baumanii’ye bağlı Trakeobronşit ve Pnömonide Antibiyoterapi ve Mortalite Oranı | |
dc.relation.journal | Southern Clinics of Istanbul Eurasia | |
dc.identifier.issue | 3 | |
dc.identifier.startpage | 191 | |
dc.identifier.endpage | 197 | |
dc.identifier.volume | 30 | |
dc.identifier.doi | 10.14744/scie.2019.58966 | |
dc.relation.issue | 3 | |
dc.relation.volume | 30 | |